Immune Checkpoint Patient Stratification: A Central Laboratory Perspective

Get in Touch

Our Locations

Immune Checkpoint Patient Stratification: A Central Laboratory Perspective

DIA China 2018 lecture

This presentation provides an overview of trends in immuno-oncology studies targeting PD-1 and PD-L1, and discusses recruitment for immune checkpoint inhibitor trials, and provides challenges and insights. This was presented by Q² Solutions at the DIA China 2018 conference.

Download this presentation to learn more.

Speaker:
Patrice Hugo, PhD, Chief Scientific Officer

Related Services & Solutions

Related Thought Leaders Insights

Scientific Poster

Evaluation of Single Cell RNA Sequencing from FFPE Tissue using 10x Genomics Chromium Gene Expression Flex Assay

Single cell RNA sequencing (scRNA-seq) uncovers tissue heterogeneity by providing gene expression measurements in individual cells within a tissue. A current limitation of scRNA-seq is the...

Scientific Poster

Comprehensive Genomic Profiling in FFPE Tissue Sample using TruSight Oncology 500 Assay

Next generation sequencing (NGS)-based comprehensive genomic profiling has emerged as a powerful tool for the large-scale detection of genomic changes. TruSight Oncology 500 (TSO500) Assay employs a...

Presentation

Single-Cell RNA Profiling of FFPE Tissues

Download this presentation to learn more about a new protocol using Chromium Gene Expression Flex to successfully and reliably conduct single cell RNA sequencing with FFPE tumor biopsy tissues. ...